aap: Update regarding antibacterial silver coating technology - Preparations for clinical human study under way

(PresseBox) ( Berlin, )
aap Implantate AG ("aap") provides an update on the recent developments regarding the aimed CE and FDA approval for its antibacterial silver coating technology. Based on the previous talks with the involved authorities as well as the internal development progress, aap will initiate various further preparations for the implementation of a clinical human study in the second half of 2017. In addition, the coordination of the design and the extent of the human study with the competent authorities will be continued. The company will publish further details about the study at the beginning of 2018. 

The internationally IP-protected silver coating technology developed by aap protects the surface of implants from bacterial colonisation. The technology thus addresses one of the critical and not yet adequately solved problems of surgery: the reduction of infection risks when using metal implants. aap's silver coating technology has several unique selling propositions such as a high coating stability as well as a good biocompatibility and effectiveness. These properties have been demonstrated in a number of different test series. Furthermore, it is a cost-effective coating technology that is scalable to higher production volumes with reasonable expense as investments for the required coating machinery are relatively low.

As a platform technology aap's silver coating technology has a wide range of applications and can be used not only in orthopaedics but also in different further areas such as cardiology, dentistry or for medical instruments.

Along with preparing for the clinical human study aap is currently in talks with various global companies on potential joint development projects in the field of silver coating technology.
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.